Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):413–419. doi: 10.1097/QAI.0000000000000489

Table 1.

Demographic and Clinical Characteristics of the Sample

Characteristic Overall N=17,044 (%)

Age (years)
    18-29 2,560 (15%)
    30-39 4,261 (25%)
    40-49 5,826 (34%)
    50-59 3,259 (19%)
    ≥ 60 1,138 (7%)

Sex
    Male 13,764 (81%)
    Female 3,289 (19%)

Race/Ethnicity
    White 6,244 (37%)
    Black 7,101(42%)
    Hispanic 2,143 (13%)
    Unknown 1,364 (8%)

HIV Risk Factor
    MSM 6,789 (40%)
    Heterosexual 4,591 (27%)
    IDU 1,850 (11%)
    Unknown 3,409 (22%)

First CD4 Count in Year
    < 350 cell/mm3 7,511 (44%)
    350-499 cell/mm3 3,669 (22%)
    ≥500 cell/mm3 4,321 (25%)
    Missing 1,534 (9%)

Use of ART in Year
    No 7,590 (45%)
    Yes 9,454 (55%)

Calendar Year
    2006 3,719 (22%)
    2007 3,510 (21%)
    2008 3,611 (21%)
    2009 3,346 (20%)
    2010 2,858 (16%)

NHAS Retention Measure
    Not Retained 1,846 (11%)
    Retained 15,198 (89%)

DHHS Retention Indicator
    Not Retained 4,473 (26%)
    Retained 12,571 (74%)

6-Month Gap
    Yes (Not Retained) 2,563 (15%)
    No (Retained) 14,481 (85%)

3-Month Visit Constancy
    1 2,901 (17%)
    2 3,586 (21%)
    3 4,806 (28%)
    4 5,751 (34%)

Viral Suppression
    No 7,119 (42%)
    Yes 8,259 (48%)
    Missing 1,666 (10%)

Abbreviations: ART, antiretroviral therapy; DHHS, Department of Health and Human Services; HET, heterosexual transmission; HIV, human immunodeficiency virus; IDU, injection drug use; MSM, men who have sex with men; NHAS, National HIV/AIDS Strategy.